Stilla Technologies: Khaled Bahi, Jerome Leclercq, Quang Tran

Stilla Technologies has added Khaled Bahi as chief financial officer, Jerome Leclercq as senior vice president for commercial operations Europe and Asia, and Quang Tran as quality and regulatory affairs director.

Bahi has more than 20 years of experience in the medtech industry in finance and operations roles, previously serving as CFO of the Swiss cardiovascular company Symetis, which was acquired by Boston Scientific. Leclercq has more than 30 years of experience in the commercialization of advanced technologies in the life sciences and previously held senior positions at Gilson and PerkinElmer. Tran has more than 20 years experience in the medtech and biotech industries in quality, regulatory, and operating roles, with previous positions at BioSerenity and Becton Dickinson, among others.